Search research articles
Contact Us
Filters
Showing results (151-160 of 169) with videos related to
Page
of 17
Sort By:
American Journal of Hematology
|
June 23, 2015
A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study
Mathilde Hunault-Berger, Thibaut Leguay, Françoise Huguet, et al.
Blood
|
April 21, 2005
Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia
Pierre Sujobert, Valerie Bardet, Pascale Cornillet-Lefebvre, et al.
Blood
|
June 7, 2024
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients
Mathieu Simonin, Loïc Vasseur, Etienne Lengliné, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2013
Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study
Amélie Trinquand, Aline Tanguy-Schmidt, Raouf Ben Abdelali, et al.
Blood Advances
|
October 9, 2020
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Damien Luque Paz, Rébecca Jouanneau-Courville, Jérémie Riou, et al.
British Journal of Haematology
|
July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO
Irit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
The Lancet. Haematology
|
December 22, 2015
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study
Patrice Chevallier, Thomas Eugene, Nelly Robillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2018
Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial
Arnaud Pigneux, Marie C Béné, Louis-Rachid Salmi, et al.
Blood
|
November 3, 2007
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results
Lionel Adès, Miguel A Sanz, Sylvie Chevret, et al.
American Journal of Hematology
|
December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients
Sylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 169) with videos related to
Sort By:
Page
of 17
American Journal of Hematology
|
June 23, 2015
A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study
Mathilde Hunault-Berger, Thibaut Leguay, Françoise Huguet, et al.
Blood
|
April 21, 2005
Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia
Pierre Sujobert, Valerie Bardet, Pascale Cornillet-Lefebvre, et al.
Blood
|
June 7, 2024
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients
Mathieu Simonin, Loïc Vasseur, Etienne Lengliné, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2013
Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study
Amélie Trinquand, Aline Tanguy-Schmidt, Raouf Ben Abdelali, et al.
Blood Advances
|
October 9, 2020
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Damien Luque Paz, Rébecca Jouanneau-Courville, Jérémie Riou, et al.
British Journal of Haematology
|
July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO
Irit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
The Lancet. Haematology
|
December 22, 2015
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study
Patrice Chevallier, Thomas Eugene, Nelly Robillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2018
Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial
Arnaud Pigneux, Marie C Béné, Louis-Rachid Salmi, et al.
Blood
|
November 3, 2007
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results
Lionel Adès, Miguel A Sanz, Sylvie Chevret, et al.
American Journal of Hematology
|
December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients
Sylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.
Page
of 17